OverviewChartNewsTraderScreen

BNP Paribas Knock-Out BRM/  DE000PE6V068  /

Frankfurt Zert./BNP
2024-09-26  5:05:15 PM Chg.-0.040 Bid5:05:36 PM Ask5:05:36 PM Underlying Strike price Expiration date Option type
2.090EUR -1.88% 2.100
Bid Size: 51,000		 2.110
Ask Size: 51,000		 BRISTOL-MYERS SQUIBB... 73.4119 - 2078-12-31 Put
GlobeNewswire 09-03 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire 09-02 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire 08-30 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 08-29 Immunocore announces transition of Chief Financial Officer
GlobeNewswire 08-28 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 08-22 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 08-15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 08-12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp 08-12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire 08-12 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire 08-08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-07 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire 08-06 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 08-05 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire 08-01 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 08-01 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 07-31 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire 07-30 Anaveon appoints Dieter Weinand as Chair of its Board of Directors
GlobeNewswire 07-25 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire 07-24 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire 07-20 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
GlobeNewswire 07-17 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...
GlobeNewswire 07-09 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...
GlobeNewswire 07-09 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire 07-08 Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors